WNT5A and melanoma: As shown in Figure 3, WNT5A silencing resulted in significant decreases in the protein levels of both total MARCKS and its active phosphorylated (Ser-159/163) form in BRAFi-sensitive melanoma cells, but no reductions were observed in either of the two BRAFi-R2 melanoma cell lines (Figure 3).